pubmed.ncbi.nlm.nih.gov/37366315 UK regulatory status retatrutide is an unlicensed investigational compound supplied strictly for research, not human consumption, as of 2026.
The relationship between weight loss and skin elasticity is complex
Set your BAC water volume Select or enter how much bacteriostatic water was used in milliliters choose from 1, 2, 3, or 5 mL presets, or enter a custom amount
Just because a medication is trending online does not mean it has been approved, regulated, or proven safe for public use
With the growing popularity of GLP-1 receptor agonists for weight loss and metabolic health, many people are now hearing about a new peptide called retatrutide
GLP-1 receptors are expressed in the heart muscle cells, immune system cells in the heart, and in the lining of blood vessels.[ref] GLP-1 RAs have been shown to help in heart failure and also to have beneficial effects on heart rhythm.[ref] Related article : Cardiovascular disease genetic risk factors Cancer Research: Retatrutide, a GLP-1/GIP/GCG triple agonist, has recently been shown to reduce pancreatic tumor mass in animals